Letter to EditorMedication errors involving opioid maintenance therapy
Section snippets
Abbreviations
- ANSM
French National Agency for Medicines and Health Products Safety
- EMA
European Medicine Agency
- FAN
French Addictovigilance Network
- FPD
French pharmacovigilance database
- HDB
high-dose buprenorphine
- ME
medication error
- OMT
opioid maintenance therapy
- OUD
opioid use disorder
We would like to draw attention to potential risks of medication errors (ME) involving opioid maintenance therapy (OMT). Methadone and high-dose buprenorphine (HDB) are effective treatments for opioid use disorders (OUD) and are widely
Disclosure of interest
The authors declare that they have no competing interest.
References (13)
- et al.
Étude « U. TOPIA » Utilisation des traitements de substitution aux opiacés en France : analyse des données de l’assurance maladie de 2009 à 2015
(2018) - et al.
Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus
Expert Opin Pharmacother
(2017) - et al.
Generalizing the use of a multidimensional approach to move towards an effective Addictovigilance
Int J Neuropsychopharmacol
(2019) - et al.
Un exemple de complémentarité entre l’évaluation des Centres Régionaux de Pharmacovigilance (CRPV) et celle des Centres d’Évaluation et d’Information sur la Pharmacodépendance (CEIP)
Therapie
(2008) - et al.
Causality assessment in pharmacovigilance: the French method and its successive updates
Therapie
(2016) - et al.
Surveillance system on drug abuse interest of the French national OPPIDUM program of French addictovigilance network
Therapie
(2017)
There are more references available in the full text version of this article.
Cited by (0)
© 2019 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved.